Private Placement

Dnotitia has open-sourced its Agent Knowledge Base, a platform that goes beyond simple RAG to create a dynamic, learning memory for enterprise AI agents.

Paris-based Ennov lands a major transatlantic investment to accelerate its AI platform, aiming to reshape global drug development and regulatory processes.

With a fresh Nasdaq listing and battle-tested tech, Duke Robotics is targeting a dual-market breakthrough in civilian and defense drone applications.

With a new $10M investment, Andorix is pioneering a fully financed model to help property owners modernize buildings with little to no upfront capital.

IGI announces ISB 2301, a first-in-class antibody targeting three tumor antigens and activating both T and NK cells for a new assault on solid tumors.

ExchangeRight's latest fund sold out fast, signaling a major investor shift toward sophisticated tax-deferred strategies and recession-proof real estate.

Canada's 'cult favorite' Asian grocer T&T arrives in San Jose, promising a new culinary era while facing a fiercely competitive local market.

Health AI firm Vi secures unicorn status with a $145M deal while launching new AI agents. But can its vision of 'health abundance' overcome ethical hurdles?

A Miami investment firm made a massive 3.86x return in 8 months by betting that power, not chips, was the real constraint on the AI industry's growth.

At the Louvre, Web3's most promising startups pitch to VCs managing billions. Discover the event forging the industry's next unicorns.

With backing from Bain Capital and Armistice, the life sciences firm's latest offering aims to fund its push to automate pharmaceutical quality control.

Preclinical data for JUST-AAV shows enhanced brain delivery and reduced side effects, offering new hope for rare neurodegenerative diseases.

Land id's new AI-powered Property Tour goes beyond static PDFs, offering dynamic, data-rich presentations that could change how real estate is sold.

A new platform, SurgeXRP, aims to democratize property investment through tokenization, launching its SGP token presale on the XRP Ledger.

Quince Therapeutics' drug LAM-001 posts strong Phase 2a data, showing meaningful functional gains for patients with severe pulmonary hypertension.

With a new CEO known for scaling operations, TSC Miami signals an aggressive move to dominate the booming on-demand and creator merchandise market.

Alaunos Therapeutics reports positive preclinical data for its oral metabolic drug, but with a perilous financial runway, the race for survival is on.

A strategic investment from Olayan Financing Company positions MS Pharma to dominate the MENA biologics market, fueling Saudi Arabia's Vision 2030 goals.

Amid tourism recovery and new delivery laws, NUGL reports strong Q1 earnings, signaling a new era for Jamaica's burgeoning regulated cannabis industry.

A new law allows VT businesses to fund 100% of green upgrades at no cost to taxpayers, promising a surge in private capital and sustainable development.